21/07/201421/10/2023 Helix BioPharma Corp. Appoints New Independent Chair Of The Board admin 0 Comments
15/07/201421/10/2023 Helix BioPharma Corp Initiates Enrollment of Ninth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47 admin 0 Comments
07/07/201421/10/2023 Helix BioPharma Corp Announces the Receipt of Subscription Agreements for a Net CAD5.4 Million Private Placement admin 0 Comments